Stockreport

Travere Therapeutics: Thriving Kidney Franchise Set To Soar On January PDUFA [Seeking Alpha]

Travere Therapeutics, Inc.  (TVTX) 
PDF TVTX's market cap has more than doubled in six months, reflecting confidence in FILSPARI's role in treating primary IgAN. Recent FDA REMS modifications for FILSPARI h [Read more]